Compare LW & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LW | LNTH |
|---|---|---|
| Founded | 1950 | 1956 |
| Country | United States | United States |
| Employees | 10100 | N/A |
| Industry | Packaged Foods | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.5B |
| IPO Year | 2016 | 2014 |
| Metric | LW | LNTH |
|---|---|---|
| Price | $44.41 | $109.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $44.14 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 1.3M | 871.8K |
| Earning Date | 04-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.29 | ★ 1.80 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $4.26 | N/A |
| Revenue Next Year | N/A | $14.19 |
| P/E Ratio | ★ $33.46 | $61.66 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $37.62 | $47.27 |
| 52 Week High | $67.07 | $111.86 |
| Indicator | LW | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 51.30 | 69.08 |
| Support Level | $40.42 | $95.00 |
| Resistance Level | $45.72 | N/A |
| Average True Range (ATR) | 1.37 | 3.16 |
| MACD | -0.12 | 0.16 |
| Stochastic Oscillator | 41.39 | 81.83 |
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.